- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03713541
Facilitators and Barriers in Anorexia Nervosa - Treatment Initiation (FABIANA)
Identification of Beneficial and Inhibitory Factors for Treatment in Patients With Anorexia Nervosa: A Pathway to Effective Secondary Prevention and Prognostic Improvement
Anorexia nervosa (AN) is a comparably low-prevalent illness. Chronic courses are often and the mortality rate of patients with AN is higher than in any other mental illness. A major influence on the course of the illness is the interval between the onset of AN symptoms and the beginning of an adequate treatment (duration of untreated illness, DUI). Patients with AN have a better prognosis if treated early. Previous large-scale interventions have not shown the desired positive effects on the DUI. Therefore, an important starting point seems to be a better initial understanding of the factors influencing the DUI, which is the major aim of this project.
The planned mixed-method study is divided in three consecutive sub-studies. The first substudy aims to identify modifiable factors influencing the DUI using semi-structured interviews and a multi-informant approach (patients, carers, physicians). As a result of this qualitative analyses using Grounded Theory the most relevant factors will be determined. The motivation of the second substudy is to condense the factors identified to influence the DUI into a checklist and to conduct a first psychometric evaluation of this newly developed instrument. The third substudy aims to quantitatively determine the magnitude of the effects of a) a priori determined non-modifiable factors and b) the modifiable checklist-factors using a multi-informant approach (planned n for each informant = 130; 13 co-operating specialized clinics and 6 cooperating outpatient partners). Additional outpatient partners may be recruited during the course of the study.
In conclusion, the study aims to derive recommendations for effective secondary prevention. Thereby, the study might ultimately contribute to earlier treatment initiation of patients with AN, and to the prevention of chronic courses and the associated high health care costs and individual burden.
Study Overview
Status
Intervention / Treatment
Detailed Description
Anorexia nervosa (AN) is a comparably low-prevalent, yet due to its somatic and mental consequences serious illness. Chronic courses are often and the mortality rate of patients with AN is higher than in any other mental illness.
A major influence on the course of the illness is the interval between the onset of AN symptoms and the beginning of an adequate treatment (duration of untreated illness, DUI). That is, patients with AN have a better prognosis if treated early. Previous large-scale interventions have not shown the desired positive effects on the DUI. Therefore, an important starting point seems to be a better initial understanding of the factors influencing the DUI, which is the major aim of this project. Based on this evidence, this study aims to derive recommendations for effective secondary prevention.
To our very best knowledge this is the first study investigating factors influencing the DUI using a multi-informant strategy, that is exploring the perspective of patients with AN, their significant carers and involved physicians. Furthermore, the study will avoid the confounding of patients with different eating disorder diagnoses, i.e. it will include exclusively patients with AN. Finally, there will be a clear focus on factors which are modifiable and precise in their definition.
The planned mixed-method study is divided in three consecutive sub-studies. The first substudy aims to identify modifiable factors influencing the DUI using semi-structured interviews and a multi-informant approach (patients, carers, physicians). As a result of this qualitative analyses using Grounded Theory the most relevant factors will be determined. The motivation of the second substudy is to condense the factors identified to influence the DUI into a checklist and to conduct a first psychometric evaluation of this newly developed instrument. The third substudy aims to quantitatively determine the magnitude of the effects of a) a priori determined non-modifiable factors and b) the modifiable checklist-factors using a multi-informant approach (planned n for each informant = 130; 13 co-operating specialized clinics and 6 cooperating outpatient partners). Additional outpatient partners may be recruited during the course of the study.
In conclusion, the study aims to derive recommendations for effective secondary prevention. Thereby, the study might ultimately contribute to earlier treatment initiation of patients with AN, and to the prevention of chronic courses and the associated high health care costs and individual burden.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Angelika Weigel, Dr.
- Phone Number: +4915222827125
- Email: a.weigel@uke.de
Study Contact Backup
- Name: Laurence Reuter, Dr.
- Phone Number: +4915222815684
- Email: l.reuter@uke.de
Study Locations
-
-
-
Bad Arolsen, Germany, 34454
- Recruiting
- Schön Clinic Bad Arolsen
-
Contact:
- M Seidel, Dr. med.
-
Bad Bevensen, Germany, 29549
- Recruiting
- Clinic Lüneburger Heide
-
Contact:
- W Wünsch-Leiteritz, Dr. med.
-
Bad Bodenteich, Germany, 29389
- Recruiting
- MediClin Seepark Clinic
-
Contact:
- Schwennen, Dr
-
Cuxhaven, Germany, 27472
- Recruiting
- Timmermann & Partner, Medical care center for physical and mental health
-
Contact:
- S Rieper
-
Hamburg, Germany, 20246
- Active, not recruiting
- Department of Child and Adolescent Psychiatry of the University Medical Center Hamburg-Eppendorf (UKE)
-
Hamburg, Germany, 20246
- Enrolling by invitation
- Local psychotherapists
-
Hamburg, Germany, 20251
- Recruiting
- Behavior therapy Falkenried MVZ GmbH
-
Contact:
- Kiki Peter
-
Hamburg, Germany, 20251
- Recruiting
- VT Falkenried Training and Education
-
Contact:
- Roman Wessels
-
Hamburg, Germany, 20559
- Recruiting
- Department of Psychosomatic Medicine and Psychotherapy, Asklepios West Clinic Hamburg
-
Contact:
- Helge Fehrs, Dr.
-
Hamburg, Germany, 22081
- Recruiting
- Schön Clinic Eilbek
-
Contact:
- Rebecca Albrecht, Dr.
-
Hamburg, Germany, 22081
- Recruiting
- Schön Clinic Hamburg Eilbek
-
Contact:
- Rebecca Albrecht, Dr.
-
Hamburg, Germany, 22085
- Enrolling by invitation
- Institute for Behavior Therapy Education Hamburg (IVAH)
-
Hamburg, Germany, 22419
- Recruiting
- Asklepios Clinic Nord - Ochsenzoll
-
Contact:
- Silke Hagena, Dipl.-Psych.
-
Regensburg, Germany, 93053
- Recruiting
- University Clinic Regensburg
-
Contact:
- Rumoald Brunner, Prof. Dr.
-
Rosengarten, Germany, 21224
- Recruiting
- Evangelic hospital Ginsterhof HmbH
-
Contact:
- Ute-Christine Haberer, Dr. med.
-
-
Bavaria
-
Prien am Chiemsee, Bavaria, Germany, 83209
- Recruiting
- Schön Clinic Roseneck
-
Contact:
- Ulrich Voderholzer, Prof. Dr.
-
-
Schleswig-Holstein
-
Bad Bramstedt, Schleswig-Holstein, Germany, 24576
- Recruiting
- Schön Clinic Bad Bramstedt
-
Contact:
- Bernhard Osen, Dr.
-
Bad Malente, Schleswig-Holstein, Germany, 23714
- Recruiting
- Curtius-Clinic, Specialist Clinic for Psychosomatics and Psychotherapeutic Medicine
-
Contact:
- Silke Kleinschmidt, Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients with AN will be recruited from n=13 inpatient clinics with special treatment units/specialized inpatient units and n=6 outpatient psychotherapists specialized for eating disorders.
Additional outpatient partner may be recruited during the course of the study.
Description
AN patients
Inclusion criteria
- Female patients, 14 years and older
- Treatment diagnosis anorexia nervosa (ICD-10: F50.0/1)
- Initial treatment (start of initial treatment no longer than 3 months ago)
- Inpatient care: at least 7 days inpatient
- Outpatient care: at least 5 sessions with the same therapist
Exclusion criteria
- Insufficient language skills
- Serious organic or psychiatric illnesses
- Acute suicidality
Significant caregiver
Inclusion criteria
- in AN patients aged 14 to 15 years: parents ; in AN patients aged 16 years and over: parents or other significant carer
- Informed consent
- Consent of the patient
Exclusion criteria - Insufficient language skills
Physician
Inclusion criteria
- Resident general practitioner, pediatrician, internist or gynecologist
- At least one medical patient contact within the last 12 months
- Informed consent
- Consent of the patient and release from confidentiality
Exclusion criteria
- Insufficient language skills
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with Anorexia nervosa (AN)
Female patients with Anorexia nervosa (AN, ICD-10: F50.0/1) of 14 years and older, receiving an initial treatment due to their AN (start of initial treatment no longer than 3 months ago, inpatient care: at least 7 days inpatient; outpatient care: at least 5 sessions with the same therapist) with sufficient language skills and no serious organic or psychiatric illnesses and no acute suicidality will be consecutively included in the study.
No intervention.
|
Survey during normal supply.
|
Carers of patients with AN
Significant caregivers in AN patients aged 14 to 15 years: parents; in AN patients aged 16 years and over: parents or other significant carer.
No intervention.
|
Survey during normal supply.
|
Physicians of patients with AN
Resident general practitioner, pediatrician, internist or gynecologist with at least one medical patient contact within the last 12 months.
No intervention.
|
Survey during normal supply.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of untreated illness (DUI in months)
Time Frame: from date of study enrolment up to 12 weeks
|
DUI (defined as the time between occurence of first symptoms and treatment) is assessed retrospectively and cross-sectional using standardized interviews and paper-and-pencil questionnaires.
|
from date of study enrolment up to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of first contact (DUC in month)
Time Frame: from date of study enrolment up to 12 weeks
|
DUC is assessed cross-sectional (retrospectively) using standardized interviews and paper-and-pencil questionnaires.
|
from date of study enrolment up to 12 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Antje Gumz, Prof. Dr., Universitätsklinikum Hamburg-Eppendorf
- Principal Investigator: Bernd Loewe, Prof. Dr., Universitätsklinikum Hamburg-Eppendorf
Publications and helpful links
General Publications
- Reuter L, Kastner D, Schmidt J, Weigel A, Voderholzer U, Seidel M, Schwennen B, Fehrs H, Lowe B, Gumz A. The development and psychometric evaluation of FABIANA-checklist: a scale to assess factors influencing treatment initiation in anorexia nervosa. J Eat Disord. 2021 Nov 3;9(1):144. doi: 10.1186/s40337-021-00490-w.
- Kastner D, Weigel A, Buchholz I, Voderholzer U, Lowe B, Gumz A. Facilitators and barriers in anorexia nervosa treatment initiation: a qualitative study on the perspectives of patients, carers and professionals. J Eat Disord. 2021 Feb 27;9(1):28. doi: 10.1186/s40337-021-00381-0.
- Kastner D, Buchholz I, Weigel A, Brunner R, Voderholzer U, Gumz A, Lowe B. Facilitators and barriers in anorexia nervosa treatment initiation (FABIANA): study protocol for a mixed-methods and multicentre study. BJPsych Open. 2019 Oct 21;5(6):e92. doi: 10.1192/bjo.2019.77.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LO 766/16-1m; GU 156
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anorexia Nervosa
-
Rosemary Claire RodenChildren's Miracle NetworkEnrolling by invitationBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3RecruitingAnorexia Nervosa | Anorexia Nervosa in Remission | Anorexia Nervosa Restricting TypeSpain
-
Duke UniversityCompletedAdolescent Anorexia Nervosa | Subthreshold Anorexia NervosaUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa | Atypical Bulimia NervosaUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Linnaeus UniversityGöteborg University; Linkoeping UniversityRecruitingBulimia Nervosa | Major Depression | Anorexia Nervosa/BulimiaSweden
-
Umeå UniversityActive, not recruitingAnorexia Nervosa | Anorexia in Adolescence | Anorexia Nervosa, AtypicalSweden
-
Yeshiva UniversityYale UniversityRecruitingAnorexia Nervosa | Bulimia Nervosa | Anorexia Nervosa, Atypical | Bulimia; AtypicalUnited States
-
The Miriam HospitalUnknownEating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia Nervosa Restricting TypeUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Atypical Anorexia NervosaUnited States
Clinical Trials on No intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States